Theravance Biopharma (TBPH) Assets (2013 - 2026)
Theravance Biopharma's Assets was $469.77 million in Q2 2026, up 10.3% from $426.04 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Assets at Theravance Biopharma came in at $485.57 million, up 37.1% from FY2024.
- Assets shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
- In earlier years, Assets was $354.16 million in FY2024 (-7.3%), $382 million in FY2023 (-37.1%), $607.4 million in FY2022 (+62.1%) and $374.82 million in FY2021 (-20.1%).
- Quarterly Assets has moved between $343.58 million (Q1 2025) and $763.5 million (Q3 2022) over five years.
- Compared with a year earlier, Assets has increased for five straight quarters, with growth averaging 11.3% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q3 2022 (growth of 89.4%); the worst was Q3 2023 (a decline of 45.8%).
- Per Business Quant data, TBPH's Assets in the three quarters before Q2 2026 was $472.31 million (Q1 2026), $485.57 million (Q4 2025) and $415.46 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 469.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 469.77 Mn |
| Mar 31, 2026 | 472.31 Mn |
| Dec 31, 2025 | 485.57 Mn |
| Sep 30, 2025 | 415.46 Mn |
| Jun 30, 2025 | 426.04 Mn |
| Mar 31, 2025 | 343.58 Mn |
| Dec 31, 2024 | 354.16 Mn |
| Sep 30, 2024 | 356.11 Mn |
| Jun 30, 2024 | 362.03 Mn |
| Mar 31, 2024 | 371.31 Mn |
| Dec 31, 2023 | 382.00 Mn |
| Sep 30, 2023 | 413.59 Mn |
| Jun 30, 2023 | 446.63 Mn |
| Mar 31, 2023 | 538.55 Mn |
| Dec 31, 2022 | 607.40 Mn |
| Sep 30, 2022 | 763.50 Mn |
| Jun 30, 2022 | 360.76 Mn |
| Mar 31, 2022 | 355.36 Mn |
| Dec 31, 2021 | 374.82 Mn |
| Sep 30, 2021 | 403.11 Mn |
API Access
Theravance Biopharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();